Insilico Medicine, Inc. is a Baltimore-based company utilizing advances in genomics and big data analysis for in silico drug discovery and drug repurposing for aging and age-related diseases. The company utilizes the GeroScope™, OncoFinder™ , Pathway Cloud Intelligence™ and PharmAtlas™ packages for aging and cancer research, pursues internal drug discovery programs, and provides services to pharmaceutical companies. For more information on Insilico Medicine, please visit http://www.insilicomedicine.com.
This blog is devoted to future of medicine, sceince, biogerontology and ageing, big data in biomedicine, robots.
Wednesday, March 11, 2015
Insilico Medicine to exhibit at NVIDIA GTC in San Jose, March 17-20
Insilico Medicine, Inc. is a Baltimore-based company utilizing advances in genomics and big data analysis for in silico drug discovery and drug repurposing for aging and age-related diseases. The company utilizes the GeroScope™, OncoFinder™ , Pathway Cloud Intelligence™ and PharmAtlas™ packages for aging and cancer research, pursues internal drug discovery programs, and provides services to pharmaceutical companies. For more information on Insilico Medicine, please visit http://www.insilicomedicine.com.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment